Back to comparisons

Comparison

Lion's Mane vs Rhodiola Rosea

FieldLion's ManeRhodiola Rosea
Categoryadaptogenadaptogen
Dose range500–3000mg200–400mg
Half-life8h4h
Onset
EvidenceEVIDENCEBEVIDENCEA
Safety●●●●●●●●●●
Legal (US)USOTCUSOTC
PubMed refs280460

The comparison in plain English

Auto-generated from data

Lion's Mane and Rhodiola Rosea are both in the adaptogen category respectively. Lion's Mane Hericium erinaceus, a medicinal mushroom whose hericenones and erinacines stimulate Nerve Growth Factor (NGF) production. Rhodiola Rosea An Arctic adaptogen used for centuries in Siberian, Scandinavian, and Tibetan traditional medicine.

Bottom line

Lion's Mane (evidence B, safety 5/5) has a stronger evidence base than Rhodiola Rosea (evidence A, safety 5/5). Lion's Mane has the slightly cleaner safety profile. For users new to either, the higher-evidence option is the safer first try.

Choose Lion's Mane if

Lion's Mane is the better fit when your goal aligns with its mechanism (Hericenones (from the fruiting body) and erinacines (from the mycelium) stimulate NGF synthesis in vitro and in vivo) and the dose range (500–3000mg) suits your protocol. Half-life is 8h.

Choose Rhodiola Rosea if

Rhodiola Rosea is the better fit when your goal aligns with its mechanism (Rosavins and salidroside (the two standardised active compounds) modulate the HPA axis cortisol response under acute stress) and the dose range (200–400mg) suits your protocol. Half-life is 4h.

Build a stack with bothOpen builder →
Check interactionsOpen checker →